Healthy Living Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.

Press releases published on September 9, 2026

Sep. 9, 2026

First Infant Data from Ascendis Trial of Once-Weekly TransCon CNP (Navepegritide) Presented at ESPE 2026

Indeterminate GlobeNewswire

Sep. 9, 2026

Genelux Announces Publication of a Deep and Durable Response in a Platinum-relapsed Small Cell Lung Cancer Patient Following Systemically Delivered Olvi-Vec-Primed Immunochemotherapy

Indeterminate GlobeNewswire

Sep. 9, 2026

Growth Exposed study finds some women dismiss safer gambling messages as "for other people"

Indeterminate EIN Presswire

Sep. 9, 2026

Sports Medicine Market to reach USD 15.60 Billion by 2035 at 7.29% CAGR

Indeterminate EIN Presswire

Sep. 9, 2026

Telemedicine Market to reach USD 479.67 Billion by 2035 at 14.18% CAGR

Indeterminate EIN Presswire

Sep. 9, 2026

Zoher F. Kapasi, PhD, PT, Named Provost of Thomas Jefferson University

Indeterminate GlobeNewswire

Sep. 9, 2026

Hardcore Teardown: How GIHOMO’s Oxygen Delivery & Safety Systems Maximize Hyperbaric Chamber Output

Indeterminate EIN Presswire

Sep. 9, 2026

AI Transforms Outpatient Surgery Through Smarter Planning and Safer Care

Indeterminate GlobeNewswire

Sep. 9, 2026

Dark Horse Consulting Group Marks the Opening of Its Shanghai Office with Ribbon Cutting Ceremony

Indeterminate GlobeNewswire

Sep. 9, 2026

Crystal Facilities Management Urges UK Businesses to Treat Office Cleaning as a Wellbeing Investment

Indeterminate EIN Presswire

Sep. 9, 2026

Sobi Receives US FDA Fast Track Designation for pacritinib in VEXAS Syndrome

Indeterminate GlobeNewswire

Sep. 9, 2026

Fast Company nombra a Visory Health en su lista de Mejores Lugares de Trabajo para Innovadores de 2026

Indeterminate GlobeNewswire

Sep. 9, 2026

Creative Biolabs Expands Integrated AI-Driven Chemical Synthesis Platforms to Accelerate Next-Generation Drug Discovery

Indeterminate EIN Presswire

Sep. 9, 2026

Association of Clinical Research Professionals Opens Applications for 2026–27 Scholarships and Grants Program

Indeterminate GlobeNewswire

Sep. 9, 2026

Why Promising Compounds Still Fail: Improving Translatability Earlier in Drug Discovery

Indeterminate EIN Presswire

Sep. 9, 2026

Cambridge Terahertz Launches People Screener 300, an AI-Powered Concealed Weapons Detection System

Indeterminate EIN Presswire

Sep. 9, 2026

Trethera Congratulates Board Director Dr. Timothy R. Donahue on Appointment to Senior Leadership Roles at Weill Cornell Medicine and NewYork-Presbyterian

Indeterminate GlobeNewswire

Sep. 9, 2026

Ladies of Porter Ranch Partners with American Red Cross for Community Blood Drive During Sickle Cell Awareness Month

Indeterminate GlobeNewswire

Sep. 9, 2026

OSE Immunotherapeutics Welcomes First Patient Dosed by Veloxis in the Phase 2 RENGEVITY-201 Trial Evaluating Pegrizeprument (VEL-101) for the Prevention of Organ Rejection in Kidney Transplant Recipients

Indeterminate GlobeNewswire

Sep. 9, 2026

OSE Immunotherapeutics se félicite de l’inclusion du premier patient traité par Veloxis dans l’étude de phase 2 RENGEVITY-201 évaluant le pegrizeprument (VEL-101) dans la prévention du rejet d’organe chez les patients transplantés rénaux

Indeterminate GlobeNewswire